It’s not easy to get depression-detecting AI through the FDA
For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life […]
📰 Original Source
Read full article at Theverge →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.